Filippo Pagani
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Annealed variational mixtures for disease subtyping and biomarker discovery.
Journal: Statistical applications in genetics and molecular biology
Published: January 08, 2025
Metastatic pheochromocytomas and paragangliomas: where are we?
Journal: Tumori
Published: May 20, 2022
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.
Journal: JCO precision oncology
Published: May 11, 2022
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Journal: International journal of cancer
Published: March 28, 2022
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 08, 2022
EpiBeds: Data informed modelling of the COVID-19 hospital burden in England.
Journal: PLoS computational biology
Published: December 04, 2021
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Journal: Cancer treatment reviews
Published: November 16, 2021
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.
Journal: Frontiers in oncology
Published: September 21, 2021
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2021
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Journal: British journal of cancer
Published: June 30, 2021
EGFR Amplification in Metastatic Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: December 14, 2020
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 03, 2020
Last Updated: 09/26/2026